PERMEABILITY OF THE CELL-WALL OF MYCOBACTERIUM-SMEGMATIS

被引:133
作者
TRIAS, J
BENZ, R
机构
[1] UNIV BARCELONA,FAC FARM,DEPT MICROBIOL & PARASITOL SANITARIES,E-08028 BARCELONA,SPAIN
[2] UNIV WURZBURG,BIOZENTRUM,THEODOR BOVERI INST,LEHRSTUHL BIOTECHNOL,D-97074 WURZBURG,GERMANY
关键词
D O I
10.1111/j.1365-2958.1994.tb01289.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The cell wall of Mycobacterium smegmatis mc(2)155 was shown to be an effective permeability barrier to hydrophilic compounds. Permeability coefficients to beta-lactams ranged from 10 x 10(-7) to 0.5 x 10(-7) cm s(-1). cell wall proteins were solubilized with EDTA and Genapol and were tested for channel-forming activity by reconstitution into lipid bilayers. Proteins were able to induce a voltage-gated cation-selective channel. The mycobacterial porin channel appeared to be water-filled since the single-channel conductance followed the mobility sequence of hydrated ions in the aqueous phase. On the basis of the Renkin equation and the single-channel conductance, the channel diameter was estimated to be around 3 nm. Model calculations showed that cation selectivity may be caused by four negative point-charges at the channel mouth. The permeability properties of the cell wall of intact cells were in good agreement with those of the reconstituted channel. Negatively charged cephalosporins, cefamandole and cephalothin, diffused at a 10- to 20-fold lower rate than the zwitterionic cephaloridine. The mycobacterial porin represents a major hydrophilic pathway of the cell wall of M. smegmatis.
引用
收藏
页码:283 / 290
页数:8
相关论文
共 37 条
[1]   TUBERCULOSIS IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].
BARNES, PF ;
BLOCH, AB ;
DAVIDSON, PT ;
SNIDER, DE .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (23) :1644-1650
[2]   STRUCTURE AND FUNCTION OF PORINS FROM GRAM-NEGATIVE BACTERIA [J].
BENZ, R .
ANNUAL REVIEW OF MICROBIOLOGY, 1988, 42 :359-393
[3]   TUBERCULOSIS - COMMENTARY ON A REEMERGENT KILLER [J].
BLOOM, BR ;
MURRAY, CJL .
SCIENCE, 1992, 257 (5073) :1055-1064
[4]  
CASTELLAN GW, 1983, PHYSICAL CHEM, P769
[5]   MYCOBACTERIUM-AVIUM INFECTION AND AIDS - A THERAPEUTIC DILEMMA IN RAPID EVOLUTION [J].
ELLNER, JJ ;
GOLDBERGER, MJ ;
PARENTI, DM .
JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (06) :1326-1335
[6]   THE EMERGENCE OF DRUG-RESISTANT TUBERCULOSIS IN NEW-YORK-CITY [J].
FRIEDEN, TR ;
STERLING, T ;
PABLOSMENDEZ, A ;
KILBURN, JO ;
CAUTHEN, GM ;
DOOLEY, SW .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (08) :521-526
[7]   TREATMENT OF 171 PATIENTS WITH PULMONARY TUBERCULOSIS RESISTANT TO ISONIAZID AND RIFAMPIN [J].
GOBLE, M ;
ISEMAN, MD ;
MADSEN, LA ;
WAITE, D ;
ACKERSON, L ;
HORSBURGH, CR .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (08) :527-532
[8]   TREATMENT OF TUBERCULOSIS IN HIV-INFECTION [J].
GROSSET, JH .
TUBERCLE AND LUNG DISEASE, 1992, 73 (06) :378-383
[9]  
HEIFETS LB, 1990, NEW ENGL J MED, V323, P419, DOI 10.1056/NEJM199008093230615
[10]   CURRENT CONCEPTS - MYCOBACTERIUM-AVIUM COMPLEX INFECTION IN THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].
HORSBURGH, CR .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (19) :1332-1338